ARTICLE | Financial News
TKTX slips after FDA's Replagal data request
January 4, 2001 8:00 AM UTC
Transkaryotic (TKTX) was down $3.313 to $33.25 on Thursday following the company's announcement after market close on Wednesday that the FDA requested additional data for its BLA for Replagal agalsida...